Discovery of PI-1840, a Novel Noncovalent and Rapidly Reversible Proteasome Inhibitor with Anti-tumor Activity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Discovery of PI-1840, a Novel Noncovalent and Rapidly Reversible Proteasome Inhibitor with Anti-tumor Activity

Published:2014-04 Issue:17 Volume:289 Page:11906-11915
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Kazi Aslamuzzaman,Ozcan Sevil,Tecleab Awet,Sun Ying,Lawrence Harshani R.,Sebti Saïd M.

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference39 articles.

1. When protein destruction runs amok, malignancy is on the loose;Pagano;Cancer Cell,2003

2. The ubiquitin-proteasome pathway and pathogenesis of human diseases;Schwartz;Annu. Rev. Med,1999

3. The development of proteasome inhibitors as anticancer drugs;Adams;Cancer Cell,2004

4. The proteasome: structure, function, and role in the cell;Adams;Cancer Treat. Rev,2003

5. The ubiquitin-proteasome proteolytic pathway;Ciechanover;Cell,1994

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Histone deacetylase (HDAC) inhibitor specificity determinants are preserved in a class of dual HDAC/non-covalent proteasome inhibitors;Bioorganic & Medicinal Chemistry;2024-04

2. Design, synthesis, and biological evaluation of some novel naphthoquinone‐glycine/β‐alanine anilide derivatives as noncovalent proteasome inhibitors;Chemical Biology & Drug Design;2023-02-17

3. Proteasome Inhibitors and Their Potential Applicability in Osteosarcoma Treatment;Cancers;2022-09-20

4. Nitazoxanide and related thiazolides induce cell death in cancer cells by targeting the 20S proteasome with novel binding modes;Biochemical Pharmacology;2022-03

5. Design, synthesis and biological evaluation of triaryl compounds as novel 20S proteasome inhibitors;Bioorganic & Medicinal Chemistry Letters;2020-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3